Biogen and Bio-Thera Announce Positive Phase 3 Results On Tocilizumab Biosimilar

Publication Date02 June 2021
SubjectClinical Trials,Prescription Drugs,Biosimilars,Pharmaceutical Industry
AuthorWilliam James
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT